Overview
- The programme recruited patients across 20 NHS sites and integrated pharmacogenomic data into electronic health records in both GP practices and hospitals.
- Genetic testing identified actionable variants affecting common medications in 95% of the first 500 participants.
- Clinicians adjusted prescriptions to safer or more effective therapies for over one in four patients based on genomic guidance.
- The informatics solution is compatible with multiple genetic testing platforms and major EHR systems, enabling seamless clinical workflow integration.
- Researchers will next assess how pharmacogenomic-informed prescribing influences follow-up appointments, emergency visits and overall medication costs.